Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An announcement from CDW Holding ( (SG:BXE) ) is now available.
CDW Holding Limited announced that its subsidiary, ABio, has signed a joint research and development agreement with Neoregen Biotech Co., Ltd. for the advancement of next-generation Lipid Nanoparticle (LNP) technology. This collaboration will allow ABio to deepen its research capabilities in LNP technology and mRNA vaccines, creating synergies through shared proprietary know-how and technology between the two companies.
More about CDW Holding
CDW Holding Limited is engaged in antibody research and drug development through its subsidiary, ABio. The company focuses on creating recombinant antibodies using its proprietary library, and is expanding into lipid nanoparticle technology as part of its market focus.
YTD Price Performance: -7.07%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.44M
See more data about BXE stock on TipRanks’ Stock Analysis page.
